nivolumab (opdivo) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Fast Track FDA Accelerated Approval FDA
Back

Drug Pricing Summary

VA Big4

$183.7383 - $2030.7700

VA FSS

$263.6071 - $2636.0700

AUS PBS

$644.0417 - $1610.1043

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
nivolumab 100 mg / 10 mL (INJECTION) $1610.1043 AUS PBS generic
  • Opdivo (1)
  • Bristol-Myers Squibb Australia Pty Ltd
    nivolumab 10 mg / 1 mL (1 mL INJECTION) $183.7383 VA Big4
  • OPDIVO (24)
  • Bristol-Myers Squibb Company
    nivolumab 10 mg / 1 mL (1 mL INJECTION) $263.6071 VA FSS
  • OPDIVO (24)
  • Bristol-Myers Squibb Company
    nivolumab 10 mg / 1 mL (1 mL INJECTION) $803.4200 VA Big4
  • OPDIVO (1)
  • Bristol-Myers Squibb Company
    nivolumab 10 mg / 1 mL (1 mL INJECTION) $1054.4200 VA FSS
  • OPDIVO (1)
  • Bristol-Myers Squibb Company
    nivolumab 10 mg / 1 mL (1 mL INJECTION) $2030.7700 VA Big4
  • OPDIVO (1)
  • Bristol-Myers Squibb Company
    nivolumab 10 mg / 1 mL (1 mL INJECTION) $2636.0700 VA FSS
  • OPDIVO (1)
  • Bristol-Myers Squibb Company
    nivolumab 40 mg / 4 mL (INJECTION) $644.0417 AUS PBS generic
  • Opdivo (1)
  • Bristol-Myers Squibb Australia Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue